NARIInari Medical, Inc.

Nasdaq inarimedical.com


$ 41.80 $ -0.99 (-2.31 %)    

Wednesday, 08-May-2024 15:59:59 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 41.82
$ 42.20
$ 0.00 x 0
$ 0.00 x 0
$ 41.49 - $ 42.60
$ 36.73 - $ 71.85
704,847
na
2.42B
$ 1.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-09-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 canaccord-genuity-maintains-buy-on-inari-medical-lowers-price-target-to-55

Canaccord Genuity analyst William Plovanic maintains Inari Medical (NASDAQ:NARI) with a Buy and lowers the price target from...

 wells-fargo-maintains-overweight-on-inari-medical-lowers-price-target-to-84

Wells Fargo analyst Larry Biegelsen maintains Inari Medical (NASDAQ:NARI) with a Overweight and lowers the price target from...

 piper-sandler-maintains-neutral-on-inari-medical-lowers-price-target-to-50

Piper Sandler analyst Adam Maeder maintains Inari Medical (NASDAQ:NARI) with a Neutral and lowers the price target from $55 ...

 needham-maintains-buy-on-inari-medical-lowers-price-target-to-57

Needham analyst Mike Matson maintains Inari Medical (NASDAQ:NARI) with a Buy and lowers the price target from $72 to $57.

 inari-medical-q1-2024-gaap-eps-042-misses-016-estimate-sales-143200m-beat-138373m-estimate

Inari Medical (NASDAQ:NARI) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.1...

 canaccord-genuity-maintains-buy-on-inari-medical-maintains-75-price-target

Canaccord Genuity analyst William Plovanic maintains Inari Medical (NASDAQ:NARI) with a Buy and maintains $75 price target.

Core News & Articles

 S&P 500 constituent APA Corp. is acquiring Callon Petroleum in a transaction expected to be completed on or about that dat...

 truist-securities-maintains-hold-on-inari-medical-lowers-price-target-to-52

Truist Securities analyst Richard Newitter maintains Inari Medical (NASDAQ:NARI) with a Hold and lowers the price target fro...

 inari-medical-announces-interim-two-year-results-from-the-clottriever-clout-registry

Inari Medical, Inc. (NASDAQ:NARI) ("Inari") a medical device company focused on developing products to treat and transf...

 needham-reiterates-buy-on-inari-medical-maintains-72-price-target

Needham analyst Mike Matson reiterates Inari Medical (NASDAQ:NARI) with a Buy and maintains $72 price target.

 why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

 needham-reiterates-buy-on-inari-medical-maintains-72-price-target

Needham analyst Mike Matson reiterates Inari Medical (NASDAQ:NARI) with a Buy and maintains $72 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION